Article
IL-18 variant increases risk of enhanced HBV DNA replication in chronic hepatitis.
Immunology letters - 1 Dec 2020
Ben Selma Walid, Alibi Sana, Smach Mohamed Ali, Saad Afef, Boukadida Jalel
Abstract excerpt
BACKGROUND: The outcome ofhepatitis B (HBV) infection is influenced by immune responses and host genetics. Interleukin-18 (IL-18) is a determinant factor in controlling the balance of Th1/Th2 during antiviral response.Weexamine therole of two functional polymorphisms -607A/C and-137A/C inIL-18 gene with risk of chronic HBV infection. METHODS AND RESULTS: Genomic DNA isolates were obtained from 200 seropositive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
